Advanced search×

Isolation of human brain endothelial cells and characterization of lipid raft-associated proteins by mass spectroscopy.

Methods Mol Biol (2011) PMID 21082377

The blood-brain barrier (BBB) limits the movements of molecules, nutrients, and cells from the systemic blood circulation into the central nervous system (CNS), and vice versa, thus allowing an optimal microenvironment for CNS development and function. The brain endothelial cells (BECs) form the primary barrier between the blood and the CNS. In addition, pericytes, neurons, and astrocytes that make up the neurovascular unit support the BEC functions and are essential to maintain this restrictive permeability phenotype. To better understand the molecular mechanisms underlying BBB properties, we propose a method to study the proteome of detergent resistant microdomain, namely lipid rafts, from human primary cultures of BECs. This chapter describes a robust human BECs isolation protocol, standard tissue culture protocols, ECs purity assessment protocols, lipid raft microdomain isolation method, and a mass spectrometry analysis technique to characterize the protein content of membrane microdomains.

DOI: 10.1007/978-1-60761-938-3_13
Version: za2963e q8za9 q8zbf q8zc9 q8zd1 q8zee q8zf1 q8zg0

Similar articles you may find interesting…

  1. Multifunctional peptide-PEG intercalating conjugates: programmatic of gene delivery to the blood-brain barrier.

    Pharm Res 27(12):2528-43 (2010) PMID 20824308

    The pPAC represent novel efficient components of GDS that could find various gene therapy applications, including genetic modulation of the BBB....
  2. Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (müllerian) type.

    Int J Gynecol Pathol 29(6):529-32 (2010) PMID 20881861

    We studied a 58-year-old woman in whom a keratinizing squamous cell carcinoma of the ovary had arisen from a mucinous cystic tumor of endocervical (müllerian) type. The tumor was interpreted initially as a transitional cell carcinoma of the ovary with marked squamous differentiation, but there was...
  3. Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.

    J Nutr 136(3):700-3 (2006) PMID 16484546

    We examined the role of PPARgamma in EAE and observed that administration of the PPARgamma agonist 15-deoxy-Delta(12,14) prostaglandin J2 exerted a significant therapeutic effect predominantly by inhibiting the activation and expansion of encephalitogenic T cells. One potential advantage in studying...